Trial Profile
Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer) Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bixalomer (Primary)
- Indications Hyperphosphataemia
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 27 Jan 2020 Status changed from active, no longer recruiting to completed.
- 15 Jan 2019 Status changed from recruiting to active, no longer recruiting.
- 26 May 2015 New trial record